Notes archive.
Sharika Enterprises auditor qualifies FY26 results, net loss deepens
Auditor flags unprovided inventory, unreconciled advances, and ₹54 cr trade receivables without credit loss assessment. Net worth turns negative.
Embassy eyes ₹6,000 Cr pre-sales in FY27 after record FY26
FY26 pre-sales up 128% to ₹4,631 Cr; company guides for 30% growth in FY27, backed by launches and ₹30,848 Cr embedded surplus.
Anuh Pharma revenue up 16%, but profit slips 13% in FY26
Top-line growth couldn't protect margins: PAT fell to ₹41.05 cr despite a ₹771.66 cr top line.
LTTS opens first AI engineering hub in Munich
The Engineering Intelligence Center of Excellence will focus on mobility, sustainability and tech; no investment or revenue guidance provided.
Swelect transfers 17.5 lakh subsidiary shares to Syrma SGS
The off-market move likely ties into a captive power arrangement with the added counterparty, but financial terms are undisclosed.
Anuh Pharma's profit slipped 13% even as revenue rose 17% in FY26
The ₹771 cr pharma company saw a margin squeeze; board recommends ₹1.50 dividend.
EPACK's RAC sales drop 24.7%; SDA and components fill the gap
Revenue fell 8.1% YoY but segment mix shifted dramatically. SDA & LDA up 32.1%, components up 50.1%. Five new customers added.
Moschip's revenue rises 25% in FY26 but margins tighten
The audited numbers confirm growth but show sequential profit decline and margin pressure. Strategic updates on Smart Energy IC and merger add context but no new surprises.
DJ Mediaprint FY26 revenue jumps 49% to ₹116.4 cr
Standalone net profit rises 53% to ₹10.0 cr; March quarter revenue nearly doubles year-on-year.
Veedol's MD exit accelerated; former MD returns June 1
Arijit Basu leaves three months early; Rajendra Nath Ghosal takes over from June 1. FY26 PAT up 8.2% to ₹135.16 crore, revenue flat at ₹1,546.96 crore.
Finkurve press release: no new financial information beyond prior disclosure
Management commentary on co-lending partnership with Godrej Finance added, but core numbers already public from board meeting outcome.
DJ Mediaprint profit leaps 53% in FY26 as Q4 revenue doubles
The nano-cap logistics player posted standalone revenue of ₹116.4 cr and net profit of ₹10.0 cr for FY26, with Q4 alone accounting for 53% of full-year earnings.
Veedol's MD exits 5 months early; ex-boss returns
Arijit Basu's resignation accelerated to May 31, 2026, with Rajendra Nath Ghosal taking over from June 1. Meanwhile, FY26 results show modest growth and a generous dividend.
Siyaram Silk Mills to issue ₹318 cr bonus preference shares
The bonus preference share issue, pegged at 12% of market cap, is a rare additional payout for shareholders. NCLT hearing already done.
Veedol accelerates MD exit, names Ghosal as successor
Modest annual results overshadowed by management shuffle: MD Basu exits May 2026, former MD Ghosal returns. Board also recommends 1100% dividend.
EPACK Durable's audited FY26 results confirm steep PAT drop, no fresh surprise
Standalone PAT fell 70% YoY to ₹17.6 crore, with a qualified audit opinion on disputed receivables. Numbers were already disclosed; the audited filing adds only routine governance changes.
Smartworks adds 4 lakh sqft in Gurugram for ₹60 cr
The expansion is 4% of operational capacity and 1.2% of market cap — incremental, not a strategic shift.
Moschip Q4 revenue up 25.5%, profit rises 5.5%
FY2026 audited results show moderate growth; audit opinion unmodified. Routine filings only.
Chatha Foods FY26 profit rises to ₹6.40 cr on revenue of ₹165.72 cr
Revenue grew from ₹157.17 cr to ₹165.72 cr, while net profit increased from ₹6.06 cr to ₹6.40 cr. An unmodified audit opinion adds no fresh surprises.
Rudra Global Infra wraps FY26 with 10% revenue growth, 15% profit growth
Audited results for Q4 and full year come in line with expectations; limited surprise for a nano-cap name.
Moschip posts 25% revenue growth but profit lags at 5.5%
Full-year results show the chip-design firm's top line expanding at nearly five times the pace of its bottom line.
EPACK Durable PAT crashes 70% on disputed receivables, PLI reversal
Standalone PAT fell to ₹17.60 cr from ₹58.23 cr; consolidated PAT nearly vanished at ₹3.26 cr. The auditor flagged ₹19.61 cr in disputed trade receivables, and the company reversed ₹32.42 cr in PLI income.
Strides Pharma's flagship plant draws 5 FDA observations
A Form 483 at the company's main manufacturing site raises the stakes for a warning letter or import ban. Response due in 15 days.
Anuh Pharma's profit slipped 13% despite 16.6% revenue growth
Revenue rose to ₹771.66 cr but PAT fell to ₹41.05 cr; board recommends ₹1.50/sh dividend.
Tata Motors PVs record 642k units; JLR plans GBP 1.7 bn reset
Q4 transcript shows 15% volume growth, EV bookings surge 25-30% after Middle East crisis, and JLR's aggressive cost plan.